We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $14.6B
1-Year Est. Return 40.95%
This Fund
S&P 500
This Quarter Est. Return
-1.84%
1 Year Est. Return
+40.95%
3 Year Est. Return
+104.32%
5 Year Est. Return
+50.55%
10 Year Est. Return
+495.11%
AUM
$11.1B
AUM Growth
-$46.6M
Cap. Flow
-$33.5M
Cap. Flow %
-0.3%
Top 10 Hldgs %
37.11%
Holding
2,111
New
475
Increased
396
Reduced
401
Closed
540

Sector Composition

Rank Sector Weight
1 Healthcare 5.32%
2 Technology 4.25%
3 Industrials 3.62%
4 Consumer Discretionary 2.28%
5 Energy 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLB icon
451
State Street Materials Select Sector SPDR ETF
XLB
$8.72B
$2.91M 0.03%
+74,122
New +$3.04M
FISV
452
Fiserv Inc
FISV
$29.7B
$2.91M 0.03%
25,723
+4,596
+22% +$566K
DVAX
453
DELISTED
Dynavax Technologies
DVAX
$2.89M 0.03%
195,700
+150,000
+328% +$2.11M
CPB icon
454
Campbell Soup
CPB
$6.85B
$2.89M 0.03%
70,300
+18,318
+35% +$801K
NVRO
455
PUT
DELISTED
NEVRO CORP.
NVRO
$2.88M 0.03%
149,800
+78,800
+111% +$1.68M
BITO icon
456
PUT
ProShares Bitcoin Strategy ETF
BITO
$1.39B
$2.87M 0.03%
207,800
+22,700
+12% +$333K
CLX icon
457
Clorox
CLX
$12B
$2.87M 0.03%
21,872
+5,903
+37% +$897K
ARKK icon
458
ARK Innovation ETF
ARKK
$5.59B
$2.85M 0.03%
71,865
+21,000
+41% +$926K
DIS icon
459
PUT
Walt Disney
DIS
$171B
$2.84M 0.03%
35,000
-22,500
-39% -$1.92M
TCOM icon
460
Trip.com Group
TCOM
$29B
$2.84M 0.03%
81,086
+72,664
+863% +$2.73M
RYTM icon
461
Rhythm Pharmaceuticals
RYTM
$7.31B
$2.83M 0.03%
123,660
-510
-0.4% -$11.4K
JNJ icon
462
CALL
Johnson & Johnson
JNJ
$640B
$2.83M 0.03%
18,200
-103,000
-85% -$17M
PHM icon
463
Pultegroup
PHM
$25.2B
$2.83M 0.03%
38,200
+19,100
+100% +$1.52M
CBRE icon
464
CBRE Group
CBRE
$43.3B
$2.81M 0.03%
38,050
-24,830
-39% -$2.06M
EQNR icon
465
Equinor
EQNR
$97.3B
$2.81M 0.03%
+85,595
New +$2.65M
ZBH icon
466
Zimmer Biomet
ZBH
$18.8B
$2.81M 0.03%
25,000
+6,480
+35% +$823K
APH icon
467
CALL
Amphenol
APH
$185B
$2.8M 0.03%
+66,600
New +$2.86M
JD icon
468
JD.com
JD
$43.5B
$2.77M 0.02%
95,027
+45,027
+90% +$1.57M
PRO
469
DELISTED
PROS Holdings
PRO
$2.75M 0.02%
79,480
+36,580
+85% +$1.26M
HYS icon
470
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.74B
$2.75M 0.02%
30,444
+3,024
+11% +$275K
ALGN icon
471
PUT
Align Technology
ALGN
$12.9B
$2.75M 0.02%
+9,000
New +$3.11M
SPLK
472
DELISTED
Splunk Inc
SPLK
$2.73M 0.02%
18,690
+8,870
+90% +$1M
EXAS
473
DELISTED
Exact Sciences
EXAS
$2.72M 0.02%
39,894
-12,715
-24% -$1.08M
QCOM icon
474
Qualcomm
QCOM
$164B
$2.72M 0.02%
24,449
+7,496
+44% +$870K
ALB icon
475
Albemarle
ALB
$13.4B
$2.7M 0.02%
15,888
+9,358
+143% +$1.86M

Similar funds

Jefferies Financial Group's Q3 2023 Portfolio in Review

As of Q3 2023, Jefferies Financial Group held 2,111 positions worth $11.1B, down 0.42% from $11.2B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jefferies Financial Group's Q3 2023 filing shows 475 new, 396 increased, 401 reduced and 540 closed positions. Its largest new stake was Axsome Therapeutics: 553,195 shares worth $38.7M. The largest sale was Allstate, an estimated $281M.

By sector, the portfolio is most concentrated in Healthcare at 5.3% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.

  • Jefferies Financial Group's largest Q3 2023 buy was Axsome Therapeutics: 553,195 shares worth $38.7M.
  • Jefferies Financial Group added most to Invesco QQQ Trust in Q3 2023, an estimated $105M increase.
  • Jefferies Financial Group's biggest Q3 2023 reduction was Allstate, cutting an estimated $281M.
  • Jefferies Financial Group fully exited State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q3 2023, selling an estimated $47.3M.
  • Jefferies Financial Group's ten largest holdings make up 37% of its $11.1B portfolio in Q3 2023.
  • Jefferies Financial Group opened 475 new positions and closed 540 in Q3 2023.
  • Jefferies Financial Group's portfolio value fell 0.42% quarter-over-quarter to $11.1B.

Based on Jefferies Financial Group's 13F filing for Q3 2023, filed 14 Nov 2023.